Stay updated on IGN002 Clinical Trial in Refractory NHL

Sign up to get notified when there's something new on the IGN002 Clinical Trial in Refractory NHL page.
Latest website image capture
Clouds background image

Latest updates to the IGN002 Clinical Trial in Refractory NHL page

  1. Check
    today
    Change Detected
    Summary
    The record describes a Phase 1 extension study of IGN002 for refractory non-Hodgkin lymphoma, including its study plan, participant criteria, locations, investigators, and outcome measures. It is listed as withdrawn for strategic reasons, with actual enrollment of zero.
    Difference
    35%
    Check dated 2026-11-08T12:23:37.000Z thumbnail image
  2. Check
    7 days ago
    Change Detected
    Summary
    The footer revision label changes from v3.7.2 to v3.8.0; the page still displays a 403 Forbidden error rather than the study record.
    Difference
    0.2%
    Check dated 2026-11-01T13:13:42.000Z thumbnail image
  3. Check
    14 days ago
    Change Detected
    Summary
    A site-wide NIH banner announces a transition in terminology from “Artificial Intelligence” to “Super Intelligence” and links to related updates and FAQs.
    Difference
    1%
    Check dated 2026-10-25T13:05:42.000Z thumbnail image
  4. Check
    21 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov footer revision changed from v3.7.1 to v3.7.2 while the page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-18T14:06:42.000Z thumbnail image
  5. Check
    28 days ago
    Change Detected
    Summary
    The study page now displays a 403 Forbidden message with a Home link instead of the prior mostly empty content area.
    Difference
    0.6%
    Check dated 2026-10-11T15:25:05.000Z thumbnail image
  6. Check
    35 days ago
    Change Detected
    Summary
    The page no longer displays the 403 Forbidden message or its Home link; no study-specific details are visible in their place.
    Difference
    0.5%
    Check dated 2026-10-04T15:36:21.000Z thumbnail image

Stay in the know with updates to IGN002 Clinical Trial in Refractory NHL

Enter your email address, and we'll notify you when there's something new on the IGN002 Clinical Trial in Refractory NHL page.